The acquisition is the latest in a series of recent deals that Indianapolis-based Eli Lilly and Co. has made to increase its cancer-treatment pipeline.

Eli Lilly is continuing its Massachusetts shopping spree, picking up a Cambridge biotech focused on blood cancer treatments ...

Earn these JavaScript certs to demonstrate mastery of the most in-demand skills for the world’s most-used programming ...

The Indianapolis-based drugmaker reported profit of $7.4 billion for the first quarter, up from $2.8 billion in the same period a year earlier.

Chelsea sack head coach Liam Rosenior after losing five consecutive Premier League matches without scoring for the first time ...

Web developers are moving away from the library wars and into a world of architectural choice. It’s about where you want the ...

We asked for your thoughts after Sunday's Premier League game between Aston Villa and Tottenham. Here are some of your ...

Insurance rates have been rising across Canada as providers respond to major weather events that are becoming increasingly ...

Hackers can now take over WordPress sites instantly using a simple plugin flaw ...

Eli Lilly to acquire Ajax Therapeutics for up to $2.3B, boosting blood cancer pipeline with a Phase 1 JAK2 inhibitor for ...

Eli Lilly continued its recent buying spree, agreeing to pay up to $2.3 billion for Ajax Therapeutics in a deal that bolsters the drugmaker’s blood-cancer portfolio.

Eli Lilly’s run of near-weekly acquisitions still shows no sign of letting up, with the Big Pharma now buying Ajax ...